Solid Biosciences (SLDB) Net Margin: 2022-2024
Historic Net Margin for Solid Biosciences (SLDB) over the last 2 years, with Dec 2024 value amounting to 50,728.00%.
- Solid Biosciences' Net Margin rose 3032602.00% to 50,728.00% in Q4 2024 from the same period last year, while for Dec 2024 it was 35,470.29%, marking a year-over-year increase of 1334957.00%. This contributed to the annual value of 35,470.29% for FY2024, which is 1339984.00% up from last year.
- Latest data reveals that Solid Biosciences reported Net Margin of 50,728.00% as of Q4 2024, which was up 26.30% from 40,165.85% recorded in Q3 2024.
- Solid Biosciences' 5-year Net Margin high stood at 50,728.00% for Q4 2024, and its period low was -1,315.22% during Q2 2022.
- Over the past 3 years, Solid Biosciences' median Net Margin value was 25,084.30% (recorded in 2023), while the average stood at 25,766.05%.
- Data for Solid Biosciences' Net Margin shows a peak YoY skyrocketed of 3,032,602bps (in 2024) over the last 5 years.
- Quarterly analysis of 3 years shows Solid Biosciences' Net Margin stood at -1,315.22% in 2022, then spiked by 2,374,225bps to 20,401.98% in 2023, then soared by 3,032,602bps to 50,728.00% in 2024.
- Its Net Margin was 50,728.00% in Q4 2024, compared to 40,165.85% in Q3 2024 and 28,762.50% in Q2 2024.